BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 16 filers reported holding BENITEC BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,088 | +13.6% | 12,950 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,718 | +23.4% | 12,950 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,202 | -45.0% | 12,950 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $4,000 | -73.3% | 12,950 | 0.0% | 0.00% | -60.0% |
| Q2 2022 | $15,000 | -50.0% | 12,950 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $30,000 | -9.1% | 12,950 | 0.0% | 0.01% | -18.2% |
| Q4 2021 | $33,000 | -28.3% | 12,950 | 0.0% | 0.01% | -31.2% |
| Q3 2021 | $46,000 | -16.4% | 12,950 | 0.0% | 0.02% | -11.1% |
| Q2 2021 | $55,000 | -16.7% | 12,950 | 0.0% | 0.02% | -18.2% |
| Q1 2021 | $66,000 | – | 12,950 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $1,796,000 | 0.06% |
| Atom Investors LP | 37,335 | $87,000 | 0.04% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 492,880 | $57,000 | 0.02% |
| WealthTrust Axiom LLC | 12,950 | $30,000 | 0.01% |
| UBS Group AG | 347 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 43 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,813 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 59,566 | $139,000 | 0.00% |